Cargando…

Identification and characterization of a novel SCYL3-NTRK1 rearrangement in a colorectal cancer patient

In colorectal cancer patients, chromosomal rearrangements involving NTRK1 gene (encoding the TRKA protein) are shown in a small subset of patients and are associated with the constitutive activation of the kinase domain of TRKA. In turn, activated TRKA-fusion proteins are associated with proliferati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Milione, Massimo, Ardini, Elena, Christiansen, Jason, Valtorta, Emanuele, Veronese, Silvio, Bosotti, Roberta, Pellegrinelli, Alessio, Testi, Adele, Pietrantonio, Filippo, Fucà, Giovanni, Wei, Ge, Murphy, Danielle, Siena, Salvatore, Isacchi, Antonella, De Braud, Filippo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589663/ https://www.ncbi.nlm.nih.gov/pubmed/28903424 http://dx.doi.org/10.18632/oncotarget.19512

Ejemplares similares

Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer
por: Sartore-Bianchi, Andrea, et al.
Publicado: (2015)

Novel CAD-ALK gene rearrangement is drugable by entrectinib in colorectal cancer
por: Amatu, Alessio, et al.
Publicado: (2015)

Entrectinib approval by EMA reinforces options for ROS1 and tumour agnostic NTRK targeted cancer therapies
por: Ardini, Elena, et al.
Publicado: (2020)

Gain of ALK Gene Copy Number May Predict Lack of Benefit from Anti-EGFR Treatment in Patients with Advanced Colorectal Cancer and RAS-RAF-PI3KCA Wild-Type Status
por: Pietrantonio, Filippo, et al.
Publicado: (2014)

Scyl1 Regulates Golgi Morphology
por: Burman, Jonathon L., et al.
Publicado: (2010)

SCYL pseudokinases in neuronal function and survival
por: Pelletier, Stephane
Publicado: (2016)

Author response to Colle et al
por: Fucà, Giovanni, et al.
Publicado: (2021)

SCYL1 does not regulate REST expression and turnover
por: Gingras, Sebastien, et al.
Publicado: (2017)

Overexpression of SCYL1 Is Associated with Progression of Breast Cancer
por: Sun, Aiqin, et al.
Publicado: (2022)

Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions
por: Brčić, Iva, et al.
Publicado: (2020)

NTRK gene fusions as novel targets of cancer therapy across multiple tumour types
por: Amatu, Alessio, et al.
Publicado: (2016)

Clonal evolution and KRAS-MET coamplification during secondary resistance to EGFR-targeted therapy in metastatic colorectal cancer
por: Sartore-Bianchi, Andrea, et al.
Publicado: (2016)

Oncogenic and drug sensitive NTRK1 rearrangements in lung cancer
por: Vaishnavi, A., et al.
Publicado: (2013)

Chemotherapy or Targeted Therapy as Second-Line Treatment of Advanced Gastric Cancer. A Systematic Review and Meta-Analysis of Published Studies
por: Iacovelli, Roberto, et al.
Publicado: (2014)

Prognostic impact of ATM mutations in patients with metastatic colorectal cancer
por: Randon, Giovanni, et al.
Publicado: (2019)

Limited Accuracy of Pan-Trk Immunohistochemistry Screening for NTRK Rearrangements in Follicular-Derived Thyroid Carcinoma
por: Macerola, Elisabetta, et al.
Publicado: (2022)

Identification and Functional Characterization of ZmSCYL2 Involved in Phytosterol Accumulation in Plants
por: Zhang, Chenchen, et al.
Publicado: (2023)

Differential histopathologic parameters in colorectal cancer liver metastases resected after triplets plus bevacizumab or cetuximab: a pooled analysis of five prospective trials
por: Cremolini, Chiara, et al.
Publicado: (2018)

TMP3-NTRK1 rearranged uterine sarcoma: A case report
por: Boyle, William, et al.
Publicado: (2020)

HGG-24. NTRK-rearranged infantile gliomas of suprasellar/ optic pathway origin
por: Lazow, Margot A, et al.
Publicado: (2022)

Imaging findings of NTRK‑rearranged spindle cell neoplasms: A case series
por: Kobayashi, Hiroshi, et al.
Publicado: (2023)

Mining potentially actionable kinase gene fusions in cancer cell lines with the KuNG FU database
por: Somaschini, Alessio, et al.
Publicado: (2020)

Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With NTRK Fusion-Positive Solid Tumors
por: Demetri, George D., et al.
Publicado: (2022)

KAOS: a new automated computational method for the identification of overexpressed genes
por: Nuzzo, Angelo, et al.
Publicado: (2016)

PoInTree: A Polar and Interactive Phylogenetic Tree
por: Marco, Carreras, et al.
Publicado: (2005)

mTORC1 controls Golgi architecture and vesicle secretion by phosphorylation of SCYL1
por: Kaeser-Pebernard, Stéphanie, et al.
Publicado: (2022)

Natural history and treatment efficacy in an ambispective case series of NTRK-rearranged mesenchymal tumors
por: Dufresne, A., et al.
Publicado: (2023)

Correction: Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients with NTRK Fusion–Positive Solid Tumors
por: Demetri, George D., et al.
Publicado: (2022)

Negative Hyperselection of Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer Who Received Panitumumab-Based Maintenance Therapy
por: Morano, Federica, et al.
Publicado: (2019)

Recurrent acute liver failure associated with novel SCYL1 mutation: A case report
por: Li, Jia-Qi, et al.
Publicado: (2019)

SCYL1 arginine methylation by PRMT1 is essential for neurite outgrowth via Golgi morphogenesis
por: Amano, Genki, et al.
Publicado: (2020)

Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer
por: Oddo, Daniele, et al.
Publicado: (2017)

Durable Clinical Response to Entrectinib in NTRK1-Rearranged Non-Small Cell Lung Cancer
por: Farago, Anna F., et al.
Publicado: (2015)

Larotrectinib in a NTRK‐rearranged soft tissue sarcoma in the neoadjuvant setting: A case report
por: Percy, Catherine, et al.
Publicado: (2021)

NTRK1 rearrangement in colorectal cancer patients: evidence for actionable target using patient-derived tumor cell line
por: Lee, Su Jin, et al.
Publicado: (2015)

Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer
por: Amatu, A, et al.
Publicado: (2019)

Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population
por: Westphalen, C. B., et al.
Publicado: (2021)

Cross platform microarray analysis for robust identification of differentially expressed genes
por: Bosotti, Roberta, et al.
Publicado: (2007)

Scyl1 Facilitates Nuclear tRNA Export in Mammalian Cells by Acting at the Nuclear Pore Complex
por: Chafe, Shawn C., et al.
Publicado: (2010)

SCYL3, as a novel binding partner and regulator of ROCK2, promotes hepatocellular carcinoma progression
por: Lei, Martina Mang Leng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_odoe8fpbp1di7noe20vpargns0